245 related articles for article (PubMed ID: 30300141)
101. Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma.
Holstein SA; Asimakopoulos F; Azab AK; Bianchi G; Bhutani M; Crews LA; Cupedo T; Giles H; Gooding S; Hillengass J; John L; Kaiser S; Lee L; Maclachlan K; Pasquini MC; Pichiorri F; Shah N; Shokeen M; Shy BR; Smith EL; Verona R; Usmani SZ; McCarthy PL
Transplant Cell Ther; 2022 Aug; 28(8):446-454. PubMed ID: 35605882
[TBL] [Abstract][Full Text] [Related]
102. Deregulation of Adaptive T Cell Immunity in Multiple Myeloma: Insights Into Mechanisms and Therapeutic Opportunities.
Leblay N; Maity R; Hasan F; Neri P
Front Oncol; 2020; 10():636. PubMed ID: 32432039
[TBL] [Abstract][Full Text] [Related]
103. Tracking the cellular immune response from early premalignancy to active multiple myeloma in a new model.
Jadhav SS; Luboshits G; Bogen B; Firer MA
Eur J Immunol; 2024 Jan; 54(1):e2350627. PubMed ID: 37872778
[TBL] [Abstract][Full Text] [Related]
104. TIGIT checkpoint inhibition for myeloma.
Asimakopoulos F
Blood; 2018 Oct; 132(16):1629-1630. PubMed ID: 30337318
[No Abstract] [Full Text] [Related]
105. Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myeloma.
Brown R; Suen H; Favaloro J; Yang S; Ho PJ; Gibson J; Joshua D
Oncoimmunology; 2012 Dec; 1(9):1658-1660. PubMed ID: 23264928
[TBL] [Abstract][Full Text] [Related]
106. Minnie SA, Kuns RD, Gartlan KH, et al. Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade. Blood. 2018;132(16):1675-1688.
Blood; 2019 Nov; 134(21):1878. PubMed ID: 31751480
[No Abstract] [Full Text] [Related]
107. THE METABOLISM OF NORMAL PLASMA PROTEINS AND GAMMA-MYELOMA PROTEIN IN MICE BEARING PLASMA-CELL TUMORS.
Humphrey JH; Fahey JL
J Clin Invest; 1961 Sep; 40(9):1696-705. PubMed ID: 16695868
[No Abstract] [Full Text] [Related]
108. Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression.
Calcinotto A; Brevi A; Chesi M; Ferrarese R; Garcia Perez L; Grioni M; Kumar S; Garbitt VM; Sharik ME; Henderson KJ; Tonon G; Tomura M; Miwa Y; Esplugues E; Flavell RA; Huber S; Canducci F; Rajkumar VS; Bergsagel PL; Bellone M
Nat Commun; 2018 Dec; 9(1):4832. PubMed ID: 30510245
[TBL] [Abstract][Full Text] [Related]
109. BH3-mimetic toolkit guides the respective use of BCL2 and MCL1 BH3-mimetics in myeloma treatment.
Gomez-Bougie P; Maiga S; Tessoulin B; Bourcier J; Bonnet A; Rodriguez MS; Le Gouill S; Touzeau C; Moreau P; Pellat-Deceunynck C; Amiot M
Blood; 2018 Dec; 132(25):2656-2669. PubMed ID: 30309889
[TBL] [Abstract][Full Text] [Related]
110. Autologous graft versus myeloma: it's not a myth.
Dong S; Ghobrial IM
J Clin Invest; 2019 Jan; 129(1):48-50. PubMed ID: 30457981
[TBL] [Abstract][Full Text] [Related]
111. Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies.
Kourelis TV; Villasboas JC; Jessen E; Dasari S; Dispenzieri A; Jevremovic D; Kumar S
Blood Cancer J; 2019 Aug; 9(9):72. PubMed ID: 31462637
[TBL] [Abstract][Full Text] [Related]
112. A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis.
Kennedy GA; Tey SK; Buizen L; Varelias A; Gartlan KH; Curley C; Olver SD; Chang K; Butler JP; Misra A; Subramoniapillai E; Morton AJ; Durrant S; Henden AS; Moore J; Ritchie D; Gottlieb D; Cooney J; Paul SK; Hill GR
Blood; 2021 Apr; 137(14):1970-1979. PubMed ID: 33512442
[TBL] [Abstract][Full Text] [Related]
113. Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation.
Henden AS; Varelias A; Leach J; Sturgeon E; Avery J; Kelly J; Olver S; Samson L; Hartel G; Durrant S; Butler J; Morton AJ; Misra A; Tey SK; Subramoniapillai E; Curley C; Kennedy G; Hill GR
Blood Adv; 2019 Oct; 3(20):3013-3019. PubMed ID: 31648324
[TBL] [Abstract][Full Text] [Related]
114. Chemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma model.
Guillerey C; Nakamura K; Pichler AC; Barkauskas D; Krumeich S; Stannard K; Miles K; Harjunpää H; Yu Y; Casey M; Doban AI; Lazar M; Hartel G; Smith D; Vuckovic S; Teng MW; Bergsagel PL; Chesi M; Hill GR; Martinet L; Smyth MJ
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31194697
[TBL] [Abstract][Full Text] [Related]
115. The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.
Ng SS; De Labastida Rivera F; Yan J; Corvino D; Das I; Zhang P; Kuns R; Chauhan SB; Hou J; Li XY; Frame TCM; McEnroe BA; Moore E; Na J; Engel JA; Soon MSF; Singh B; Kueh AJ; Herold MJ; Montes de Oca M; Singh SS; Bunn PT; Aguilera AR; Casey M; Braun M; Ghazanfari N; Wani S; Wang Y; Amante FH; Edwards CL; Haque A; Dougall WC; Singh OP; Baxter AG; Teng MWL; Loukas A; Daly NL; Cloonan N; Degli-Esposti MA; Uzonna J; Heath WR; Bald T; Tey SK; Nakamura K; Hill GR; Kumar R; Sundar S; Smyth MJ; Engwerda CR
Nat Immunol; 2020 Oct; 21(10):1205-1218. PubMed ID: 32839608
[TBL] [Abstract][Full Text] [Related]
116. TIM-3
Minnie SA; Waltner OG; Zhang P; Takahashi S; Nemychenkov NS; Ensbey KS; Schmidt CR; Legg SRW; Comstock M; Boiko JR; Nelson E; Bhise SS; Wilkens AB; Koyama M; Dhodapkar MV; Chesi M; Riddell SR; Green DJ; Spencer A; Furlan SN; Hill GR
Sci Immunol; 2024 Apr; 9(94):eadg1094. PubMed ID: 38640253
[TBL] [Abstract][Full Text] [Related]
117. Progress and prospect of ASCT combined with CAR-T therapy in the treatment of multiple myeloma.
Yuan S; Chen Y; Liu H
Ther Adv Hematol; 2024; 15():20406207241237594. PubMed ID: 38481949
[TBL] [Abstract][Full Text] [Related]
118. Regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantation.
Takahashi S; Minnie SA; Ensbey KS; Schmidt CR; Sekiguchi T; Legg SRW; Zhang P; Koyama M; Olver SD; Collinge AD; Keshmiri S; Comstock ML; Varelias A; Green DJ; Hill GR
Blood; 2024 Apr; 143(16):1656-1669. PubMed ID: 38295333
[TBL] [Abstract][Full Text] [Related]
119. Single-cell analysis of the CD8
Favaloro J; Bryant CE; Abadir E; Gardiner S; Yang S; King T; Nassif N; Sedger LM; Boyle R; Joshua DE; Ho PJ
Haematologica; 2024 Apr; 109(4):1220-1232. PubMed ID: 37794800
[TBL] [Abstract][Full Text] [Related]
120. Harnessing Dendritic Cells: Next Frontier for Durable Immune Control in Myeloma.
Dhodapkar MV
Clin Cancer Res; 2023 Nov; 29(22):4524-4526. PubMed ID: 37737650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
